In this state-of-the-art review, the authors summarize current antithrombotic strategies for patients undergoing complex PCI and discuss evidence from randomized clinical trials evaluating these regimens in this context. https://t.co/ul5CqPP87Q
Key teaching points when you switch P2Y12i
Acute<30 d: Always bolus
Don't wait if you escalate from clopidogrel.
For de-escalation: wait 24h
Chronic >30d: Wait 24h
Give maintenance dose except when switching from ticagrelor to prasugrel/clopidogrel (give bolus)
State-of-the-art in @EuroInterventio
Comprehensive review on bioprosthetic valve dysfunction after TAVI: mechanisms, diagnosis, and management. Midterm BVF incidence remains low (<5%), with SVD as the key driver. Durability appears comparable to SAVR. @TernacleJ @PPibarot #EAPCI #EIJBestOf
This study explored the use of paclitaxel-coated balloons for stabilizing vulnerable lipid-rich plaques in ACS patients. Discover how this approach could reduce future coronary events. #Cardiology#ACS
https://t.co/3rZgbQxeCS
FFR vs iFR
Both are invasive physiological measurements used to assess the significance of coronary artery stenosis during coronary angiography.
● FFR (Fractional Flow Reserve):
Ratio of the maximum achievable blood flow in a diseased coronary artery to the theoretical maximum flow in a normal coronary artery.
● iFR (Instantaneous wave-Free Ratio):
Measures pressure gradient across a coronary stenosis during a specific part of the cardiac cycle (diastole's "wave-free period") when resistance is naturally low.
When to Use Each?
✅ Use iFR for simpler, faster assessment without drugs.
✅ Use FFR when hyperemic data is critical or in borderline cases.
🔴Orthostatic Hypotension: A Practical Approach⤵️
🔹Is defined as a decrease in blood pressure of
1️⃣0 mm Hg or more diastolic or
2️⃣0 mm Hg or more systolic within
3️⃣ minutes of standing from the supine position
🔹https://t.co/xdHlPk5RG7
We use diuretics every day in the ICU. Prescribing them is never a one-size-fits-all approach. This paper reviews different strategies we can utilize with our patients. 🎩 tip to the authors!
https://t.co/wtiQFg1wGN
Te perdiste el Congreso #ACC25 ?
Resumo en español los principales ensayos presentados: IC, TAVI, INOCA, anticoagulación, IA y más.
�� Todo en un hilo / imágenes para repasar lo más relevante del congreso.
🫀 ¿Cuál cambiaría tu práctica?
#ACC2025 #CardioTwitter #MedEd #EvidenceBasedMedicine #HeartFailure #CardioLatam
Paclitaxel or Sirolimus-coated balloons in coronary bifurcations? Is the side branch SPACIOUS enough for both?
In this editorial, Daniele Giacoppo comments on the SPACIOUS trial, exploring the role of DCBs for side branch treatment in bifurcation lesions.
Sirolimus-based DCBs showed non-inferiority vs paclitaxel-based DCBs in terms of diameter stenosis, with lower binary restenosis rates.
https://t.co/Scp6NqBCbR
#InterventionalCardiology #DCB #CoronaryBifurcation #SPACIOUStrial #CardiologyResearch #EAPCI
Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice: @SpringerNature
🥸 We reviewed few key points for the use of drug-coated balloons in practice: @MichaelGNanna@DNFeldmanMD
😱 Here are few highlights:
👇👇👇
🎧Escucha en mi podcast este interesante y práctico paper publicado recientemente en JAMA Cardiology❤️ sobre cómo utilizar apropiadamente el score de calcio: demasiado temprano, demasiado tarde, demasiado frecuente:
https://t.co/dkd0sfp3MX
👇Mucho más:
https://t.co/7ms2AgcNiY